BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 6118943)

  • 1. H2 receptor antagonists: ultrastructure of canine parietal cells after long term treatment with ranitidine.
    Ainge G; Poynter D
    Scand J Gastroenterol Suppl; 1981; 70():143-54. PubMed ID: 6118943
    [No Abstract]   [Full Text] [Related]  

  • 2. Long term effects of H2-receptor antagonists (cimetidine and ranitidine) on the human gastric and duodenal mucosa.
    Ribet A; Balas D; Bastie MJ; Senegas-Balas F; Escourrou J; Bommelaer G; Pradayrol L
    Scand J Gastroenterol Suppl; 1981; 70():155-74. PubMed ID: 6118944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A review of the animal pharmacology of ranitidine--a new, selective histamine H2-antagonist.
    Brittain RT; Daly MJ
    Scand J Gastroenterol Suppl; 1981 Jun; 69():1-9. PubMed ID: 6119770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction of histamine with gastric mucosal cells. Effect of histamine H2 antagonists on binding and biological response.
    Batzri S; Harmon JW; Dyer J; Thompson WF
    Mol Pharmacol; 1982 Jul; 22(1):41-7. PubMed ID: 6126804
    [No Abstract]   [Full Text] [Related]  

  • 5. A comparison of some of the pharmacological properties of etintidine, a new histamine H2-receptor antagonist, with those of cimetidine, ranitidine and tiotidine.
    Cavanagh RL; Usakewicz JJ; Buyniski JP
    J Pharmacol Exp Ther; 1983 Jan; 224(1):171-9. PubMed ID: 6129316
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Dose-dependent effects of ranitidine on the transmural potential difference of the stomach].
    von Kleist D; Zschiedrich M; Stopik D; Hampel KE
    Arzneimittelforschung; 1981; 31(6):1038-40. PubMed ID: 6114738
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gastric acid response to topical or intravenous histamine and topical H2-receptor blockade in dogs.
    Konturek SJ; Cieszkowski M; Kwiecień N; Harrison C
    Agents Actions; 1981 Nov; 11(5):437-41. PubMed ID: 6121473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stereological analysis of the parietal cell during acid secretion and inhibition.
    Zalewsky CA; Moody FG
    Gastroenterology; 1977 Jul; 73(1):66-74. PubMed ID: 16808
    [No Abstract]   [Full Text] [Related]  

  • 9. [Ranitidine and transmural potential difference. Results with sodium taurocholate (author's transl)].
    Müller P; Fischer N; Kather H; Simon B; Dammann HG
    Dtsch Med Wochenschr; 1981 Nov; 106(47):1577-9. PubMed ID: 6118248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The new histamine H2-receptor antagonist ranitidine. Duration of action.
    Dammann HG; Simon B
    Scand J Gastroenterol Suppl; 1981 Jun; 69():39-43. PubMed ID: 6119781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the effect of omeprazole--a substituted benzimidazole--and ranitidine--a potent H2-receptor antagonist--on histamine-induced gastric acid secretion and the ultrastructure of canine parietal cells.
    Stachura J; Konturek SJ; Cieszkowsky M; Dabroś W; Zakrzewska J; Konturek J
    Hepatogastroenterology; 1983 Oct; 30(5):205-10. PubMed ID: 6315556
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ranitidine and other H2-receptor antagonists: recent developments.
    Daly MJ; Price BJ
    Prog Med Chem; 1983; 20():337-68. PubMed ID: 6138817
    [No Abstract]   [Full Text] [Related]  

  • 13. Ranitidine and intragastric pH profiles in seriously ill patients.
    Dammann HG; Flasshoff D; Müller P; Kather H; Simon B
    Dig Dis Sci; 1982 Feb; 27(2):187-8. PubMed ID: 6122547
    [No Abstract]   [Full Text] [Related]  

  • 14. [Ranitidine: consequences on secretory function and gastric mucosa].
    Vallot T; Cadiot G
    Rev Med Suisse Romande; 1995 Oct; 115(10):773-80. PubMed ID: 7501929
    [No Abstract]   [Full Text] [Related]  

  • 15. [Influence of ranitidine on antipyrine metabolism (author's transl)].
    Staiger C; Simon B; de Vries J; Kather H; Walter E
    Z Gastroenterol; 1980 Dec; 18(12):601-4. PubMed ID: 6116365
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of ranitidine (inhibitor of H2 receptors) after i.v. injection to patients treated in an intensive care unit: control of gastric acid secretion and estimation of drug plasma levels.
    Macchi H; Fiasse R; Reynaert M; Desager JP; Dive C
    Arch Int Pharmacodyn Ther; 1982 Apr; 256(2):306-7. PubMed ID: 6125133
    [No Abstract]   [Full Text] [Related]  

  • 17. Ranitidine (AH 19065): a new potent, selective histamine H2-receptor antagonist [proceedings].
    Bradshaw J; Brittain RT; Clitherow JW; Daly MJ; Jack D; Price BJ; Stables R
    Br J Pharmacol; 1979 Jul; 66(3):464P. PubMed ID: 43178
    [No Abstract]   [Full Text] [Related]  

  • 18. Stimulation of gastric acid secretion by intravenous amino acid infusion and its inhibition by H2-receptor antagonists ranitidine and cimetidine.
    Weingart J; Kunert H; Ottenjann R
    Scand J Gastroenterol Suppl; 1981 Jun; 69():61-5. PubMed ID: 6119784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kinetics and duration of action of ranitidine on gastric secretion and its effect on pancreatic secretion in duodenal ulcer patients.
    Konturek SJ; Obtułowicz W; Kwiecień N; Kopp B; Oleksy J
    Scand J Gastroenterol Suppl; 1981 Jun; 69():91-9. PubMed ID: 6119789
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of cimetidine and ranitidine on mucosal potential difference.
    von Kleist D; Stopik D; Hampel KE
    Lancet; 1979 Nov; 2(8151):1071-2. PubMed ID: 91804
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.